GLP-1
(Glucagon-like peptide-1) has become the most disruptive mechanism in metabolic
health, driving explosive growth in weight management and blood sugar
regulation markets.
However,
pharmaceutical GLP-1 receptor agonists face key challenges:

This
opens a major opportunity for natural GLP-1-related ingredients.
DHMSober™
is a high-purity Dihydromyricetin (DHM) extracted from vine tea,
developed by Shanghai Aidu Biotechnology.
Traditionally
known for:
传统上以:
Now, new
research highlights its metabolic regulation potential, making it
relevant in the GLP-1-driven market.

While DHMSober™ is not a GLP-1 agonist,
studies suggest it may interact with related metabolic pathways:
1. Supports Endogenous GLP-1 Secretion
DHM may influence gut signaling and
microbiota activity, indirectly supporting GLP-1 release.
2. Potential DPP-4 Modulation
DPP-4 is responsible for GLP-1 degradation.
DHM shows potential in slowing this process.
3. AMPK Activation
Improves insulin sensitivity and energy
metabolism — overlapping with GLP-1 benefits.
4. Anti-inflammatory & Antioxidant
Effects
Reduces metabolic stress, a key driver of
insulin resistance and aging.
✔ Multi-functional Positioning
Liver health
Metabolic support
Sports recovery
One ingredient, multiple claims
✔ GLP-1 Compatible Formulation
Ingredient
Can be used in:
Weight management formulas
Blood sugar support products
Longevity & metabolic blends
✔ Supply Chain Advantage
Manufactured by Shanghai Aidu Biotechnology
DHMSober™ is suitable for:
The market is evolving into three layers:
DHMSober™ sits at the intersection of natural
+ metabolic + scalable.
Shanghai Aidu Biotechnology is a
manufacturer and supplier of herbal extracts for:
Dietary supplements
Longevity
technology (Longevity Science)
Sports nutrition
Functional food industry
DHMSober™ is one of its flagship
ingredients, offering:
Looking for:
Contact Aidu Biotechnology today to
explore DHMSober™ opportunities